A collaborative, patient reported outcome (PRO)-based approach by palliative care and radiation oncology teams results in better outpatient symptom management and a decrease in end-of-life hospitalizations and costs for late-stage cancer patients, according to new research.
An updated breast cancer screening guideline from the American Cancer Society (ACS) recommends that women at average risk start regular annual mammography screening at age 45 and transition to screening every two years starting at age 55.
IBA announced that Korea’s National Cancer Center (NCC) has recently installed and deployed its pencil beam scanning (PBS) delivery modality. On Sept. 22, PBS treatment was initiated for the first cancer patient to benefit from the superior precision of this delivery technique in Korea.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
For high-risk patients who receive chemoradiation therapy for head and neck cancer, frequent follow-up appointments conducted by advance practice nurses (APN) in a clinical outpatient setting allowed for more intensive symptom management. This program resulted in fewer post-treatment emergency room visits and hospital admissions compared to historical outcomes, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
In October, Siemens Healthcare debuted a host of imaging systems that enable RT professionals to go further in the direction of personalized therapy.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The American College of Radiology (ACR) spoke out against the U.S. Preventive Services Task Force’s (USPSTF) exclusion of computed tomography (CT) colonography from its most recent list of recommended exams for colorectal cancer screening, saying the decision could be a significant blow to efforts to raise colorectal cancer screening rates.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
October 20, 2015 — For cervical cancer patients undergoing postsurgical radiation therapy, image-guided intensity ...
Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the VPAC1 molecular biomarker 64Cu TP-3805 exclusively for clinical trials for the biopharmaceutical firm NuView Life Sciences Inc., of Park City, Utah.
Immunotherapy combined with palliative radiation therapy (RT) for a subset of patients with metastatic melanoma reduces the growth and spread of the cancer, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Orfit Industries introduced and demonstrated its HP Pro Solution, an innovative, comprehensive and versatile immobilization system for proton therapy, at the American Society for Radiation Oncology (ASTRO) 57th annual meeting. The technology, designed for brain, head and neck treatments, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
For some early-stage breast cancer patients, accelerated partial breast irradiation (APBI) using multicatheter brachytherapy following breast conserving surgery may be an excellent treatment option. In new research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting, APBI was proven to be as effective as the current standard treatment – whole breast irradiation (WBI) – in local control, disease-free and overall survival rates.
For some patients with human papilloma virus (HPV)-related cancer of the tonsils and tongue, reduced intensity radiation therapy (RT) and chemotherapy may be as effective as standard-dose radiation and chemotherapy, and result in less acute side effects. This conclusion came from research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting, Oct. 18-21 in San Antonio.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Brainlab announced a major sales milestone with its Airo Mobile Intraoperative CT (computed tomography) scanner, with acquisitions by 50 hospitals in just a little over a year since the first shipment. University of Utah Health Care and Henry Ford Hospital round out the facilities to have already acquired Airo for enhanced surgical decision-making.
The main pumping chamber of the heart ages differently in men and women, according to a new magnetic resonance imaging (MRI) study published online in the journal Radiology. Researchers said the findings may support different treatment approaches for men and women with heart disease.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
IBA (Ion Beam Applications S.A.) announced the successful response of over 120 attendees for the live webinar “Electronic Recordkeeping in Radiation Therapy” delivered Sept. 23, 2015. The webinar was hosted by Medical Physics Web with funding provided by an IBA educational grant and was presented by James Nunn, MS, CHP, DABR, senior medical physicist at LewisGale Regional Hospital in Virginia.
Findings from a new population-based study in the Netherlands appear to reaffirm that early detection of breast cancer positively impacts long-term patient survival.
“Survival kit contents check. In them you'll find: One .45 caliber automatic; two boxes of ammunition; four days’ ...
lifeIMAGE announced its participation in the 2015 Cerner Health Conference (CHC), Cerner’s annual healthcare event taking place in Kansas City, Missouri, Oct. 11 – 14.
The eight-page Centricity Universal Viewer Zero Footprint (ZFP) Resource Guide from GE Healthcare provides an interactive solution for physicians who are looking to gain more information about this mobile viewing tool with anytime, anywhere access, where Internet is available.
Gamma Medica Inc. announced the CE Mark approval allowing for the sale and distribution of the LumaGEM Molecular Breast Imaging (MBI) system within the European Economic Area (EEA). Gamma Medica is finalizing distribution partners in strategic markets across the EEA.